Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889

Published:2003-07-10 Issue:5 Volume:106 Page:799-805
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Endo Mika,Miwa Masanori,Eda Hiroyuki,Ura Masako,Tanimura Hiromi,Ishikawa Tohru,Miyazaki-Nose Taeko,Hattori Kazuo,Shimma Nobuo,Yamada-Okabe Hisafumi,Ishitsuka Hideo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Degradation of pyrimidines and pyrimidine analogs—Pathways and mutual influences

2. Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of drug-metabolizing enzymes in synthetic lethality of cancer;Pharmacology & Therapeutics;2022-12

2. Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution;ACS Pharmacology & Translational Science;2022-10-06

3. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review;Drug Metabolism Reviews;2021-01-02

4. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it;Drug Metabolism Reviews;2019-04-03

5. Drug delivery of oral anti-cancer fluoropyrimidine agents;Expert Opinion on Drug Delivery;2017-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP